NCT05634954 - Study to Evaluate Safety and Dosimetry of [18F]GEH121224 in Patients With Locally Advanced or Metastatic Breast Cancer | Biotech Hunter

Timeline

Start Date

February 28, 2026

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions

Breast Cancer

Interventions

DRUG

GEH121224 (18F) Injection

Single GEH121224 (18F) Injection

DIAGNOSTIC_TEST

Dynamic and Static - PET/CT Scan

Group 1: Dynamic whole-body PET/CT scan will start at the time of injection (8 sequential scans over 90 minutes anticipated) followed by static whole-body scans starting at 120 minutes and 240 minutes after injection.

DIAGNOSTIC_TEST

Static - PET/CT Scan

Group 2: Static whole-body scans

Trial Locations (1)

77030-4008

The University of Texas MD Anderson Cancer Centre, Houston